SP-MHCI-1274-2

Glutamate decarboxylase 2 114-122, VMNILLQYV

US$169.00

Limited stock

Description

About Glutamate decarboxylase 2 114-122, VMNILLQYV

The Human Glutamate decarboxylase 2 Peptide (IEDB: 104336) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Glutamate decarboxylase Peptide, H-VMNILLQYV-OH (Uniprot: Q05329 aa: 114-122) from JPT is produced under strict quality control and quality management.

Glutamate decarboxylase 2 114-122, VMNILLQYV - Specifications

  • Peptide sequence: H-VMNILLQYV-OH
  • Amount: 1 mg
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Diabetes
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Glutamate decarboxylase 2 114-122, VMNILLQYV

References:
Read References with JPT’s Antigen Peptides

Glutamate decarboxylase 2 114-122, VMNILLQYV has been described in:
Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes., J Immunol, 2007 (PMID: 17947651.0)
Detection of GAD65 autoreactive T-cells by HLA class I tetramers in type 1 diabetic patients., J Biomed Biotechnol, 2009 (PMID: 20029631.0)
Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative., Diabetes Metab Res Rev, 2011 (PMID: 22069251.0)

Documentation

Documentation for Glutamate decarboxylase 2 114-122, VMNILLQYV

Properties

Properties of Glutamate decarboxylase 2 114-122, VMNILLQYV

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Diabetes
Layout: Freeze-dried in glass vial
Organism: Human
Protein Name: Glutamate decarboxylase
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No

Further Information to Glutamate decarboxylase 2 114-122, VMNILLQYV

Information Values
Sequence: H-VMNILLQYV-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote